FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?

PURPOSE: The value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-positron emission tomography (PET)-radiomics in the outcome assessment of patients with recurrent glioblastoma (rGBM) has not been evaluated until now. The aim of this study was to evaluate whether a prognostic model based on FET-PET radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Carles, Montserrat, Popp, Ilinca, Starke, Michael Maximilian, Mix, Michael, Urbach, Horst, Schimek-Jasch, Tanja, Eckert, Franziska, Niyazi, Maximilian, Baltas, Dimos, Grosu, Anca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931514/
https://www.ncbi.nlm.nih.gov/pubmed/33658069
http://dx.doi.org/10.1186/s13014-020-01744-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931514/
https://www.ncbi.nlm.nih.gov/pubmed/33658069
http://dx.doi.org/10.1186/s13014-020-01744-8

Ejemplares similares